Radiofrequency ablation of hepatocellular carcinoma sized > 3 and &le; 5 cm: Is ablative margin of more than 1 cm justified?

doi:10.3748/wjg.v19.i42.7389

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 42

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5623)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-4) series.

Item

Count

PDF

429

HTML

3017

Figures (1-3)

227

Tables (1-4)

184

Sum=3857

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

826

Download

940

Sum=1766

Nov 14, 2013 (publication date) through Jul 20, 2024

Times Cited of This Article

Times Cited (30)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastroenterol. Nov 14, 2013; 19(42): 7389-7398
Published online Nov 14, 2013. doi: 10.3748/wjg.v19.i42.7389

Full Size Figure Download Figure

Figure 1 Flow diagram of the enrollment and follow-up. A total of 281 patients met the inclusion criteria. HCC: Hepatocellular carcinoma; RF: Radiofrequency; TACE: transcatheter arterial chemoembolization; AM: Ablative margin.

Citation: Ke S, Ding XM, Qian XJ, Zhou YM, Cao BX, Gao K, Sun WB. Radiofrequency ablation of hepatocellular carcinoma sized > 3 and ≤ 5 cm: Is ablative margin of more than 1 cm justified? World J Gastroenterol 2013; 19(42): 7389-7398
URL: https://www.wjgnet.com/1007-9327/full/v19/i42/7389.htm
DOI: https://dx.doi.org/10.3748/wjg.v19.i42.7389